Comparing Caliber Imaging & Diagnostics (OTCMKTS:LCDX) and Inogen (NASDAQ:INGN)

Inogen (NASDAQ:INGNGet Free Report) and Caliber Imaging & Diagnostics (OTCMKTS:LCDXGet Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Institutional and Insider Ownership

89.9% of Inogen shares are held by institutional investors. 1.0% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Inogen and Caliber Imaging & Diagnostics’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Inogen $326.65 million 0.89 -$102.45 million ($4.15) -2.96
Caliber Imaging & Diagnostics N/A N/A N/A ($0.75) N/A

Caliber Imaging & Diagnostics has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Caliber Imaging & Diagnostics, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Inogen and Caliber Imaging & Diagnostics, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inogen 1 2 1 0 2.00
Caliber Imaging & Diagnostics 0 0 0 0 N/A

Inogen presently has a consensus target price of $7.00, suggesting a potential downside of 42.95%.

Profitability

This table compares Inogen and Caliber Imaging & Diagnostics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Inogen -28.30% -45.37% -28.57%
Caliber Imaging & Diagnostics N/A N/A N/A

Summary

Caliber Imaging & Diagnostics beats Inogen on 5 of the 9 factors compared between the two stocks.

About Inogen

(Get Free Report)

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

About Caliber Imaging & Diagnostics

(Get Free Report)

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.

Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.